Vincent J. Willey

2.5k citations

91 papers · 1.8k indexed · h-index 23

Surgery top 5%
Endocrinology, Diabetes and Metabolism top 2%
Economics and Econometrics top 2%
Cardiology and Cardiovascular Medicine top 5%
Epidemiology

Co-authors: Michael Bullano Mark J. Cziraky Siddhesh Kamat Maxine D. Fisher Ole Hauch David M. Kern Chaitanya Sarawate Gail Wygant
Topics: Diabetes Treatment and Management (20 papers)Health Systems, Economic Evaluations, Quality of Life (19 papers)Lipoproteins and Cardiovascular Health (16 papers)
Cited by: Family Practice Internal Medicine Geriatrics and Gerontology
Journals: Circulation Journal of Clinical Oncology Cancer
Partner nations: United States United Kingdom Germany

In The Last Decade

Vincent J. Willey

85 papers receiving 1.8k citations

Peers

Countries citing papers authored by Vincent J. Willey

Since Specialization

Citations

This map shows the geographic impact of Vincent J. Willey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent J. Willey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent J. Willey more than expected).

Fields of papers citing papers by Vincent J. Willey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent J. Willey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent J. Willey. The network helps show where Vincent J. Willey may publish in the future.

Co-authorship network of co-authors of Vincent J. Willey

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent J. Willey. A scholar is included among the top collaborators of Vincent J. Willey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent J. Willey. Vincent J. Willey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative Safety of Glucagon‐Like Peptide 1 Receptor Agonists ( GLP ‐1‐ RAs ) in Type 2 Diabetes and Chronic Weight Management: A Real‐World Data Study 2025 ·Pharmacoepidemiology and Drug Safety ·Sarah R. Hoffman,Stephan Lanes,(unknown),(unknown),Jeff White,(unknown),Mark J. Cziraky,Matthew J. Crowley,Vincent J. Willey	0
2	Patient Perspectives on the Burden of Heart Failure with Preserved Ejection Fraction in a US Commercially Insured and Medicare Advantage Population: A Survey Study 2023 ·Patient Preference and Adherence ·(unknown),Luke Bamber,Vincent J. Willey,Thomas Evers,Thomas P. Power,Judith J. Stephenson	1
3	Rigorous and rapid evidence assessment in digital health with the evidence DEFINED framework 2023 ·npj Digital Medicine ·Jordan Silberman,Paul Wicks,(unknown),(unknown),Siyeon Park,Igor O. Korolev,Jenna R. Carl,Jocelynn T. Owusu,Vimal Mishra,Manpreet Kaur,Vincent J. Willey,Mădălina Sucală,(unknown),Cindy Geoghegan,Isaac R. Rodriguez‐Chavez,Benjamin Vandendriessche,(unknown),Jennifer C. Goldsack	17
4	P21 Machine Learning for Imputing Missing Pharmacy Costs in Claims Data 2023 ·Value in Health ·(unknown),John Barron,Ashwini Kumar,Michael Grabner,Birhanu Eshete,Hiangkiat Tan,Vincent J. Willey	1
5	Impact of pre‐existing type 2 diabetes with and without cardiovascular disease on patients with COVID ‐19 2023 ·Diabetes Obesity and Metabolism ·(unknown),Christopher L. Crowe,Effie Kuti,(unknown),B.M.K. Donato,(unknown),(unknown),Leo Seman,(unknown),Thomas P. Power,(unknown),Vincent J. Willey	0
6	New insights into the optimal management of COPD: extracts from CHEST 2021 annual meeting (October 17–20, 2021) 2022 ·Expert Review of Respiratory Medicine ·Jennifer K Quint,Jukka Montonen,Dave Singh,Herbert Wachtel,(unknown),Swetha Palli,(unknown),Vincent J. Willey,(unknown)	4
7	<p>Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study</p> 2020 ·ClinicoEconomics and Outcomes Research ·Jay Visaria,Neeraj N. Iyer,Amit D. Raval,Sheldon X. Kong,Todd Hobbs,Jonathan Bouchard,David M. Kern,Vincent J. Willey	20
8	Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and Medicare Advantage population 2018 ·BMJ Open ·Vincent J. Willey,(unknown),(unknown),Cheng Wang,Stephen Sander,Hiangkiat Tan,(unknown),Rahul Jain	14
9	Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab 2018 ·Clinical Therapeutics ·Xuehua Ke,Abhishek Kavati,Debra Wertz,Qing Huang,Liya Wang,Vincent J. Willey,Judith J. Stephenson,Benjamin Ortiz,Reynold A. Panettieri,Jonathan Corren	10
10	A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data 2017 ·PubMed ·David M. Kern,John J. Barron,Bingcao Wu,Alex Ganetsky,Vincent J. Willey,Ralph Quimbo,Michael Fisch,Joseph Singer,(unknown),Ronac Mamtani	13
11	Abstract 15102: Treatment and Persistence With Oral Anticoagulants Among Newly Diagnosed Patients With Non-Valvular Atrial Fibrillation in a Commercially Insured and Medicare Advantage Population 2016 ·Circulation ·Rahul Jain,(unknown),(unknown),Cheng Wang,Stephen Sander,Hiangkiat Tan,(unknown),Vincent J. Willey	0
12	Spirometry: Tool for pharmacy practitioners to expand direct patient care services 2013 ·Journal of the American Pharmacists Association ·Michael J. Cawley,Jean Moon,(unknown),Vincent J. Willey,(unknown)	12
13	Epidemiologic study of aripiprazole use and the incidence of suicide events 2010 ·Pharmacoepidemiology and Drug Safety ·Marianne Ulcickas Yood,Gerald N. DeLorenze,Charles P. Quesenberry,Ai‐Lin Tsai,(unknown),Vincent J. Willey,Steve J. Niemcryk,Karen Wells,Mary Lou Skovron,Mark J. Cziraky,William H. Carson,Susan A. Oliveria	16
14	Disparities in medical care among commercially insured patients with newly diagnosed breast cancer 2009 ·Cancer ·Louise J. Short,Maxine D. Fisher,Peter Wahl,(unknown),Grant Lawless,Sandra White,Nancy A. Rodriguez,Vincent J. Willey,Otis W. Brawley	31
15	Beyond the myths: finding benefit design solutions that address the true costs of high healthcare use. 2008 ·PubMed ·Vincent J. Willey,(unknown),Grant Lawless	5
16	Prevalence and Humanistic Impact of Potential Misdiagnosis of Bipolar Disorder Among Patients With Major Depressive Disorder in a Commercially Insured Population 2008 ·Journal of Managed Care Pharmacy ·Siddhesh Kamat,Krithika Rajagopalan,(unknown),Vincent J. Willey,Michael Bullano,Mariam Hassan	26
17	Agreement Between Administrative Claims and the Medical Record in Identifying Patients With a Diagnosis of Hypertension 2006 ·Medical Care ·Michael Bullano,Siddhesh Kamat,Vincent J. Willey,Suna Barlas,Douglas J. Watson,Susan K. Brenneman	41
18	Monitoring anticoagulation in atrial fibrillation 2006 ·Journal of Thrombosis and Thrombolysis ·Chaitanya Sarawate,Mirko Sikirica,Vincent J. Willey,Michael Bullano,Ole Hauch	30
19	Effect of Rosuvastatin Compared with Other Statins on Lipid Levels and National Cholesterol Education Program Goal Attainment for Low‐Density Lipoprotein Cholesterol in a Usual Care Setting 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Michael Bullano,Debra Wertz,(unknown),Siddhesh Kamat,Gerald M. Borok,Sanjay Gandhi,(unknown),Vincent J. Willey	51
20	Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy 2004 ·PharmacoEconomics ·Joshua S. Benner,Jonothan C. Tierce,Christie M. Ballantyne,(unknown),Michael Bullano,Vincent J. Willey,John R. Erbey,David Sugano	90

About Vincent J. Willey

Vincent J. Willey is a scholar working on Family Practice, Endocrinology, Diabetes and Metabolism and Geriatrics and Gerontology, having authored 91 papers that have together received 1.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (20 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers) and Lipoproteins and Cardiovascular Health (16 papers). The work is most often cited by research in Family Practice (144 citations), Internal Medicine (169 citations) and Geriatrics and Gerontology (124 citations). Vincent J. Willey has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Michael Bullano, Mark J. Cziraky, Siddhesh Kamat, Maxine D. Fisher, Ole Hauch, David M. Kern, Chaitanya Sarawate, Gail Wygant, Lauren A. Hoffman and Alex C. Spyropoulos. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact